Concepedia

Heejun Son

HS

Statistics

Publications

1

Citations

61

H-Index

1

Active since

2023

Affiliations

Samsung (South Korea)(Current)

Heejun Son is an author at Samsung (South Korea) specializing in diabetes mellitus, medicine, and cancer prevention.

ORCID

Publications per year

2023–2023

1

Publications

1

Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study

Sungho Bea, Heejun Son, Jae Hyun Bae et al. · Diabetes Obesity and Metabolism · 2023 · 61 citations

, , +16

1–1 of 1